262 related articles for article (PubMed ID: 19413666)
1. Is albumin infusion necessary after large volume paracentesis?
Cárdenas A; Ginès P; Runyon BA
Liver Int; 2009 May; 29(5):636-40; discussion 640-1. PubMed ID: 19413666
[No Abstract] [Full Text] [Related]
2. Prevention of paracentesis-induced circulatory dysfunction: midodrine vs albumin. A randomized pilot study.
Appenrodt B; Wolf A; Grünhage F; Trebicka J; Schepke M; Rabe C; Lammert F; Sauerbruch T; Heller J
Liver Int; 2008 Aug; 28(7):1019-25. PubMed ID: 18410283
[TBL] [Abstract][Full Text] [Related]
3. Comparison of midodrine and albumin in the prevention of paracentesis-induced circulatory dysfunction in cirrhotic patients: a randomized pilot study.
Hamdy H; ElBaz AA; Hassan A; Hassanin O
J Clin Gastroenterol; 2014 Feb; 48(2):184-8. PubMed ID: 23842215
[TBL] [Abstract][Full Text] [Related]
4. Albumin infusion fails to restore circulatory function following paracentesis of tense ascites as assessed by beat-to-beat haemodynamic measurements.
Schneditz D; Bachler I; Stadlbauer V; Stauber RE
Int J Clin Pract; 2008 Dec; 62(12):1851-7. PubMed ID: 17927765
[TBL] [Abstract][Full Text] [Related]
5. Does the evidence support a survival benefit of albumin infusion in patients with cirrhosis undergoing large-volume paracentesis?
Bernardi M; Caraceni P; Navickis RJ
Expert Rev Gastroenterol Hepatol; 2017 Mar; 11(3):191-192. PubMed ID: 28004601
[No Abstract] [Full Text] [Related]
6. [Albumin infusion for paracentesis in patients with cirrhosis: dogma or evidence?].
Manzocchi S; Nendaz M; Spahr L
Rev Med Suisse; 2012 Oct; 8(358):1956, 1958-60. PubMed ID: 23198648
[TBL] [Abstract][Full Text] [Related]
7. Prevention of paracentesis-induced circulatory dysfunction in cirrhosis: standard vs half albumin doses. A prospective, randomized, unblinded pilot study.
Alessandria C; Elia C; Mezzabotta L; Risso A; Andrealli A; Spandre M; Morgando A; Marzano A; Rizzetto M
Dig Liver Dis; 2011 Nov; 43(11):881-6. PubMed ID: 21741331
[TBL] [Abstract][Full Text] [Related]
8. Terlipressin versus albumin in paracentesis-induced circulatory dysfunction in cirrhosis: a randomized study.
Singh V; Kumar R; Nain CK; Singh B; Sharma AK
J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 2):303-7. PubMed ID: 16460491
[TBL] [Abstract][Full Text] [Related]
9. Treatment of cirrhotic tense ascites with Dextran-40 versus albumin associated with large volume paracentesis: a randomized controlled trial.
García-Compean D; Blanc P; Larrey D; Daures JP; Hirtz J; Mendoza E; Maldonado H; Michel H
Ann Hepatol; 2002; 1(1):29-35. PubMed ID: 15114293
[TBL] [Abstract][Full Text] [Related]
10. Albumin infusion in patients undergoing large-volume paracentesis: a meta-analysis of randomized trials.
Bernardi M; Caraceni P; Navickis RJ; Wilkes MM
Hepatology; 2012 Apr; 55(4):1172-81. PubMed ID: 22095893
[TBL] [Abstract][Full Text] [Related]
11. Midodrine versus albumin in the prevention of paracentesis-induced circulatory dysfunction in cirrhotics: a randomized pilot study.
Singh V; Dheerendra PC; Singh B; Nain CK; Chawla D; Sharma N; Bhalla A; Mahi SK
Am J Gastroenterol; 2008 Jun; 103(6):1399-405. PubMed ID: 18547224
[TBL] [Abstract][Full Text] [Related]
12. Paracentesis-Induced Circulatory Dysfunction With Modest-Volume Paracentesis Is Partly Ameliorated by Albumin Infusion in Acute-on-Chronic Liver Failure.
Arora V; Vijayaraghavan R; Maiwall R; Sahney A; Thomas SS; Ali R; Jain P; Kumar G; Sarin SK
Hepatology; 2020 Sep; 72(3):1043-1055. PubMed ID: 31849085
[TBL] [Abstract][Full Text] [Related]
13. Long-term clinical outcome of large volume paracentesis with intravenous albumin in patients with spontaneous bacterial peritonitis: a randomized prospective study.
Choi CH; Ahn SH; Kim DY; Lee SK; Park JY; Chon CY; Moon YM; Han KH
J Gastroenterol Hepatol; 2005 Aug; 20(8):1215-22. PubMed ID: 16048569
[TBL] [Abstract][Full Text] [Related]
14. An update on the pathogenesis and clinical management of cirrhosis with refractory ascites.
Neong SF; Adebayo D; Wong F
Expert Rev Gastroenterol Hepatol; 2019 Apr; 13(4):293-305. PubMed ID: 30791777
[TBL] [Abstract][Full Text] [Related]
15. Randomized trial comparing albumin and saline in the prevention of paracentesis-induced circulatory dysfunction in cirrhotic patients with ascites.
Sola-Vera J; Miñana J; Ricart E; Planella M; González B; Torras X; Rodríguez J; Such J; Pascual S; Soriano G; Pérez-Mateo M; Guarner C
Hepatology; 2003 May; 37(5):1147-53. PubMed ID: 12717396
[TBL] [Abstract][Full Text] [Related]
16. Tense ascites in cirrhosis: paracentesis with albumin infusion versus spontaneous ascites filtration.
Robson SC
HPB Surg; 1994; 7(4):336-40. PubMed ID: 8204557
[No Abstract] [Full Text] [Related]
17. Use of albumin in patients with cirrhosis: misuse or misconception?
Kumar R
Natl Med J India; 2011; 24(2):123-4. PubMed ID: 21668072
[No Abstract] [Full Text] [Related]
18. At bat with paracentesis: home runs or singles?
Simon D
Am J Gastroenterol; 1991 Jan; 86(1):110. PubMed ID: 1986537
[No Abstract] [Full Text] [Related]
19. Colloids Versus Albumin in Large Volume Paracentesis to Prevent Circulatory Dysfunction: Evidence-based Case Report.
Widjaja FF; Khairan P; Kamelia T; Hasan I
Acta Med Indones; 2016 Apr; 48(2):148-55. PubMed ID: 27550886
[TBL] [Abstract][Full Text] [Related]
20. AISF-SIMTI Position Paper: The appropriate use of albumin in patients with liver cirrhosis.
;
Dig Liver Dis; 2016 Jan; 48(1):4-15. PubMed ID: 26802734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]